The Danish Diabetes Association
13
1
1
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 13 trials
100.0%
+13.5% vs industry average
8%
1 trials in Phase 3/4
0%
0 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (13)
Trajectories in Insulin Sensitivity Across MEnstrual cycleS in Women With Type 1 Diabetes
Role: collaborator
Physical Activity and Mortality in Type 2 Diabetes
Role: collaborator
Handball-based Exercise and Type 2 Diabetes
Role: collaborator
The Together on Diabetes Intervention - a Realist Evaluation
Role: collaborator
Survey of People With Diabetes, Caregivers of People With Diabetes Parents of Children and Young People With Diabetes
Role: collaborator
Intervention Study - Effectiveness of Smartphone Delivered Interval Walking Training to Patients With Type 2 Diabetes
Role: collaborator
Optimized Glycemic Control in Heart Failure Patients With DM2:"Effect on Left Ventricular Function and Skeletal Muscle"
Role: collaborator
GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia
Role: collaborator
VLDL-triglyceride Kinetics in Type 2 Diabetes
Role: collaborator
Study of Postprandial Incretin Response in Women With Gestational Diabetes
Role: collaborator
Alpha-Cell Sensitivity to GLP-1 in Patients With Type 2 Diabetes
Role: collaborator
Basal Insulins - Pharmacodynamics
Role: collaborator
Characterizing and Diagnosis's of the Charcot Foot (Charcot Osteoarthropathy) in Diabetic Patients
Role: collaborator
All 13 trials loaded